Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris

ClinicalTrials.gov ID: NCT03170388

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03170388. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 6:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris

Study identification

NCT ID
NCT03170388
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
741 participants

Conditions and interventions

Eligibility (public fields only)

Age range
9 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 5, 2017 (Actual)
Primary completion
Apr 23, 2019 (Actual)
Completion
Apr 23, 2019 (Actual)
Last update posted
Nov 10, 2021

2017 – 2019

United States locations

U.S. sites
29
U.S. states
20
U.S. cities
27
Facility City State ZIP Site status
Valeant Site 02 Hot Springs Arkansas 71913 —
Valeant Site 07 Fremont California 94538 —
Valeant Site 08 Sacramento California 95819 —
Valeant Site 09 Denver Colorado 80220 —
Valeant Site 11 Boynton Beach Florida 33437 —
Valeant Site 13 North Miami Beach Florida 33162 —
Valeant Site 12 Sanford Florida 32771 —
Valeant Site 10 West Palm Beach Florida 33401 —
Valeant Site 15 Marietta Georgia 30060 —
Valeant Site 14 Snellville Georgia 30078 —
Valeant Site 16 Boise Idaho 83704 —
Valeant Site 17 Overland Park Kansas 66215 —
Valeant Site 18 Louisville Kentucky 40217 —
Valeant Site 19 Louisville Kentucky 40241 —
valeant Site 21 Glenn Dale Maryland 20769 —
Valeant Site 20 Needham Massachusetts 02492 —
Valeant Site 22 Detroit Michigan 48202 —
Valeant Site 24 Morristown New Jersey 07960 —
Valeant Site 25 Albuquerque New Mexico 87106 —
Valeant Site 27 New York New York 10022 —
Valeant Site 26 New York New York 10075 —
Valeant Site 23 High Point North Carolina 27262 —
Valeant Site 28 Gresham Oregon 97030 —
Valeant Site 30 Johnston Rhode Island 02919 —
Valeant Site 31 Nashville Tennessee 37215 —
Valeant Site 32 Austin Texas 78759 —
Valeant Site 33 Pflugerville Texas 78660 —
valeant Site 34 San Antonio Texas 78213 —
Valeant Site 35 Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03170388, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 10, 2021 · Synced Nov 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.